An Exploratory Study of Endorectal Magnetic Resonance Imaging and Spectroscopy of the Prostate as Preoperative Predictive Biomarkers of Biochemical Relapse After Radical Prostatectomy

被引:14
作者
Zakian, Kristen L. [1 ]
Hricak, Hedvig
Ishill, Nicole
Reuter, Victor E.
Eberhardt, Steven
Moskowitz, Chaya S.
Shukla-Dave, Amita
Wang, Liang
Scardino, Peter T.
Eastham, James A.
Koutcher, Jason A.
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
prostate; prostatic neoplasms; neoplasm recurrence; magnetic resonance spectroscopy; magnetic resonance imaging; TUMOR VOLUME; INDEPENDENT PREDICTOR; ANTIGEN RECURRENCE; LIPID SUPPRESSION; GLEASON SCORE; CANCER; MR; PROGRESSION; NOMOGRAM; MEN;
D O I
10.1016/j.juro.2010.07.037
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Radical prostatectomy has significant side effects. Preoperative information predicting its long-term outcome would be valuable to patients and physicians. We determined whether pretreatment endorectal magnetic resonance imaging/magnetic resonance spectroscopic imaging predicts biochemical recurrence after radical prostatectomy. Materials and Methods: Of 202 patients who underwent endorectal magnetic resonance imaging/magnetic resonance spectroscopic imaging from January 2000 to December 2002 before radical prostatectomy 130 satisfied study inclusion criteria and were included in analysis. We compared imaging factors with potential predictive capability to biochemical recurrence data, including magnetic resonance imaging risk score based on local disease extent and magnetic resonance spectroscopic imaging index lesion characteristics, such as the number of voxels and degree of metabolic abnormality (magnetic resonance spectroscopic imaging grade). We evaluated associations of these imaging variables with time to biochemical recurrence by Cox proportional hazards regression adjusted for known predictors of biochemical recurrence, such as stage, grade and prostate specific antigen. Results: At a median 68-month followup there were 26 biochemical failures. Risk score, lesion volume and high grade voxels each correlated with time to biochemical recurrence. In a model combining clinical parameters risk score, lesion volume and at least 1 high grade voxel the magnetic resonance spectroscopic imaging variables remained significant but the magnetic resonance imaging score dropped out. Conclusions: Index lesion volume on magnetic resonance spectroscopic imaging and high grade magnetic resonance spectroscopic imaging voxels correlate with time to biochemical recurrence after radical prostatectomy even when adjusted for clinical data. Results suggest the preoperative predictive usefulness of endorectal magnetic resonance imaging/magnetic resonance spectroscopic imaging in patients considering radical prostatectomy.
引用
收藏
页码:2320 / 2327
页数:8
相关论文
共 31 条
  • [11] Preoperative and Postoperative Nomograms Incorporating Surgeon Experience for Clinically Localized Prostate Cancer
    Kattan, Michael W.
    Vickers, Andrew J.
    Yu, Changhong
    Bianco, Fernando J.
    Cronin, Angel M.
    Eastham, James A.
    Klein, Eric A.
    Reuther, Alwyn M.
    Pontes, Jose Edson
    Scardino, Peter T.
    [J]. CANCER, 2009, 115 (05) : 1005 - 1010
  • [12] Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
    Kattan, MW
    Wheeler, TM
    Scardino, PT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1499 - 1507
  • [13] KATTAN MW, 1998, J Natl CANC I, V90, P90
  • [14] Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.1-cm(3)) spatial resolution
    Kurhanewicz, J
    Vigneron, DB
    Hricak, H
    Narayan, P
    Carroll, P
    Nelson, SJ
    [J]. RADIOLOGY, 1996, 198 (03) : 795 - 805
  • [15] Males RG, 2000, MAGNET RESON MED, V43, P17, DOI 10.1002/(SICI)1522-2594(200001)43:1<17::AID-MRM3>3.0.CO
  • [16] 2-6
  • [17] Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer
    Nakashima, J
    Tanimoto, A
    Imai, Y
    Mukai, M
    Horiguchi, Y
    Nakagawa, K
    Oya, M
    Ohigashi, T
    Marumo, K
    Murai, M
    [J]. UROLOGY, 2004, 64 (01) : 101 - 105
  • [18] Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer
    Nelson, BA
    Shappell, SB
    Chang, SS
    Wells, N
    Farnham, SB
    Smith, JA
    Cookson, MS
    [J]. BJU INTERNATIONAL, 2006, 97 (06) : 1169 - 1172
  • [19] NELSON SJ, 1995, ANN SCI M EUR SOC MA
  • [20] Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers
    Noguchi, M
    Stamey, TA
    McNeal, JE
    Yemoto, CM
    [J]. JOURNAL OF UROLOGY, 2000, 164 (05) : 1596 - 1600